Bumper Offer - Urjas oil Just @ Rs. 1
Ibolme CT 20/6.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ibolme CT 20/6.25 Tablet is used -
Moderate
Mild
Common
Is the use of Ibolme CT 20/6.25 Tablet safe for pregnant women?
Ibolme CT shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Ibolme CT 20/6.25 Tablet safe during breastfeeding?
Breastfeeding women can take Ibolme CT as it bears very minor side effects for them.
What is the effect of Ibolme CT 20/6.25 Tablet on the Kidneys?
Ibolme CT rarely affects the kidneys.
What is the effect of Ibolme CT 20/6.25 Tablet on the Liver?
Ibolme CT may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Ibolme CT 20/6.25 Tablet on the Heart?
Side effects of Ibolme CT rarely affect the heart.
Ibolme CT 20/6.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ibolme CT 20/6.25 Tablet unless your doctor advises you to do so -
Is this Ibolme CT 20/6.25 Tablet habit forming or addictive?
Ibolme CT 20/6.25 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Ibolme CT 20/6.25 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Ibolme CT 20/6.25 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Ibolme CT 20/6.25 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Ibolme CT 20/6.25 Tablet
Ibolme CT 20/6.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Ibolme CT 20/6.25 Tablet
Consuming Ibolme CT 20/6.25 Tablet with alcohol can have many serious effects on your body.
Yes, Ibolme CT can be taken at night but you are advised to take it in the morning to avoid sleep disturbances caused by excessive urination during the night.
Yes, you may take Ibolme CT with metoprolol as it will help in reducing high blood pressure and slow the heart rate. But using this combination may cause some side effects like dizziness, weakness, fainting, fast or irregular heartbeats, or loss of blood glucose control. If you experience any of these side effects then consult it with your doctor immediately.
Yes, Ibolme CT may cause hair loss. If you are experiencing severe hair loss after taking this drug, you are advised to consult it with your doctor.
No, Ibolme CT is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because it can cause very unpleasant side effects. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
Ibolme CT works by increasing the rate of urine formation by inhibiting the sodium and potassium reabsorption in the kidney, this causes more frequent urination than normal. The increased flow of urination leads to a decrease in blood volume that helps in the relaxation of the walls of blood vessels and this results in a decrease in blood pressure.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173